2023 annual financial data

Jasper Therapeutics 2023 Operating margin

Direct answer

Operating margin was Not calculable.

Operating income was -68.86M USD and net income was -64.47M USD.
Operating cash flow was -52.07M USD.

Get free Jasper Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-68.86M USD
Net income
-64.47M USD
Operating cash flow
-52.07M USD